New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
thorax.bmj6d
Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity
Respiratory syncytial virus (RSV) is the most common viral pathogen associated ... While the exact causes of pathology during RSV infection are still contested, the data suggest that pulmonary ...
Frontiers6d
Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia
Introduction: Respiratory syncytial virus (RSV) vaccines targeting the fusion glycoprotein ... lung-infiltrating cells, and lung pathology. Results: mG with any adjuvant was ineffective at inducing ...
EurekAlert!5d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
The technology could be adapted for other common respiratory viruses such as seasonal influenza, avian flu and respiratory syncytial virus (RSV ... also a professor of molecular microbiology and of ...
‘Stigma’: Participant in aborted UQ Covid vaccine trial still returning false positive HIV tests four years on
A Brisbane man who took part in the University of Queensland’s aborted Covid vaccine trial is still returning “false positive” HIV tests four years later.
News Medical on MSN4d
Study explores the impact of respiratory bacteria on RSV severity
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...
Medscape7d
Rapid Antigen-based Testing for Respiratory Syncytial Virus
Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...